Table 4.
Tumor selectivity advantages (SA) of D & PEG-MNPs with respect to normal brain
| MNP | No Magnetic Targeting | Magnetic Targeting |
|---|---|---|
| D | 1.1 | 16 |
| D5 | 6.0 | 27 |
| D20 | 4.8 | 29 |
Tumor selectivity advantages (SA) of D & PEG-MNPs with respect to normal brain
| MNP | No Magnetic Targeting | Magnetic Targeting |
|---|---|---|
| D | 1.1 | 16 |
| D5 | 6.0 | 27 |
| D20 | 4.8 | 29 |